nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—ALOX5—hematologic cancer	0.338	1	CbGaD
Zileuton—UGT1A9—Irinotecan—hematologic cancer	0.0266	0.0622	CbGbCtD
Zileuton—CYP1A2—Anagrelide—hematologic cancer	0.0254	0.0593	CbGbCtD
Zileuton—PTGS1—Bortezomib—hematologic cancer	0.0241	0.0564	CbGbCtD
Zileuton—PTGS1—Thalidomide—hematologic cancer	0.021	0.0492	CbGbCtD
Zileuton—PTGS1—Ifosfamide—hematologic cancer	0.0185	0.0433	CbGbCtD
Zileuton—PTGS1—Imatinib—hematologic cancer	0.0177	0.0413	CbGbCtD
Zileuton—CYP2C9—Bexarotene—hematologic cancer	0.0158	0.0371	CbGbCtD
Zileuton—CYP1A2—Carmustine—hematologic cancer	0.0133	0.0312	CbGbCtD
Zileuton—CYP2C9—Idarubicin—hematologic cancer	0.0131	0.0307	CbGbCtD
Zileuton—CYP1A2—Methoxsalen—hematologic cancer	0.0113	0.0265	CbGbCtD
Zileuton—CYP1A2—Bortezomib—hematologic cancer	0.0108	0.0252	CbGbCtD
Zileuton—CYP1A2—Daunorubicin—hematologic cancer	0.0103	0.0241	CbGbCtD
Zileuton—CYP1A2—Alitretinoin—hematologic cancer	0.0101	0.0236	CbGbCtD
Zileuton—CYP2C9—Bortezomib—hematologic cancer	0.00971	0.0227	CbGbCtD
Zileuton—CYP1A2—Thalidomide—hematologic cancer	0.00939	0.022	CbGbCtD
Zileuton—CYP3A4—Bexarotene—hematologic cancer	0.00921	0.0215	CbGbCtD
Zileuton—PTGS1—Etoposide—hematologic cancer	0.00884	0.0207	CbGbCtD
Zileuton—CYP3A4—Busulfan—hematologic cancer	0.00856	0.02	CbGbCtD
Zileuton—CYP3A4—Lomustine—hematologic cancer	0.00856	0.02	CbGbCtD
Zileuton—CYP2C9—Thalidomide—hematologic cancer	0.00846	0.0198	CbGbCtD
Zileuton—CYP1A2—Dacarbazine—hematologic cancer	0.00807	0.0189	CbGbCtD
Zileuton—CYP2C9—Teniposide—hematologic cancer	0.00807	0.0189	CbGbCtD
Zileuton—CYP1A2—Imatinib—hematologic cancer	0.00789	0.0185	CbGbCtD
Zileuton—CYP3A4—Thiotepa—hematologic cancer	0.00763	0.0179	CbGbCtD
Zileuton—CYP2C9—Ifosfamide—hematologic cancer	0.00745	0.0174	CbGbCtD
Zileuton—CYP2C9—Imatinib—hematologic cancer	0.00711	0.0166	CbGbCtD
Zileuton—CYP2C9—Nilotinib—hematologic cancer	0.00646	0.0151	CbGbCtD
Zileuton—CYP1A2—Dasatinib—hematologic cancer	0.00634	0.0148	CbGbCtD
Zileuton—CYP3A4—Methoxsalen—hematologic cancer	0.00593	0.0139	CbGbCtD
Zileuton—CYP3A4—Bortezomib—hematologic cancer	0.00564	0.0132	CbGbCtD
Zileuton—CYP3A4—Daunorubicin—hematologic cancer	0.0054	0.0126	CbGbCtD
Zileuton—CYP3A4—Cytarabine—hematologic cancer	0.00476	0.0111	CbGbCtD
Zileuton—CYP3A4—Teniposide—hematologic cancer	0.00469	0.011	CbGbCtD
Zileuton—CYP3A4—Ifosfamide—hematologic cancer	0.00433	0.0101	CbGbCtD
Zileuton—CYP3A4—Imatinib—hematologic cancer	0.00414	0.00968	CbGbCtD
Zileuton—CYP1A2—Etoposide—hematologic cancer	0.00395	0.00924	CbGbCtD
Zileuton—CYP3A4—Ruxolitinib—hematologic cancer	0.00389	0.00911	CbGbCtD
Zileuton—CYP3A4—Nilotinib—hematologic cancer	0.00376	0.00879	CbGbCtD
Zileuton—CYP3A4—Vinorelbine—hematologic cancer	0.00373	0.00872	CbGbCtD
Zileuton—LTB4R—hematopoietic system—hematologic cancer	0.00368	0.115	CbGeAlD
Zileuton—CYP2C9—Cisplatin—hematologic cancer	0.00362	0.00847	CbGbCtD
Zileuton—CYP3A4—Triamcinolone—hematologic cancer	0.00341	0.00798	CbGbCtD
Zileuton—CYP3A4—Dasatinib—hematologic cancer	0.00332	0.00777	CbGbCtD
Zileuton—CYP3A4—Mitoxantrone—hematologic cancer	0.00328	0.00768	CbGbCtD
Zileuton—CYP2C9—Dexamethasone—hematologic cancer	0.00293	0.00685	CbGbCtD
Zileuton—CYP3A4—Betamethasone—hematologic cancer	0.00292	0.00684	CbGbCtD
Zileuton—CYP3A4—Prednisolone—hematologic cancer	0.00289	0.00675	CbGbCtD
Zileuton—CYP3A4—Prednisone—hematologic cancer	0.00272	0.00638	CbGbCtD
Zileuton—CYP3A4—Irinotecan—hematologic cancer	0.00258	0.00604	CbGbCtD
Zileuton—LTB4R—blood—hematologic cancer	0.00244	0.076	CbGeAlD
Zileuton—LTB4R—bone marrow—hematologic cancer	0.00236	0.0735	CbGeAlD
Zileuton—CYP3A4—Vinblastine—hematologic cancer	0.0023	0.00537	CbGbCtD
Zileuton—CYP3A4—Vincristine—hematologic cancer	0.00226	0.00528	CbGbCtD
Zileuton—LTB4R—lung—hematologic cancer	0.00214	0.0666	CbGeAlD
Zileuton—CYP3A4—Etoposide—hematologic cancer	0.00207	0.00484	CbGbCtD
Zileuton—LTB4R—testis—hematologic cancer	0.00202	0.0629	CbGeAlD
Zileuton—EPHX2—blood—hematologic cancer	0.0018	0.0559	CbGeAlD
Zileuton—CYP3A4—Dexamethasone—hematologic cancer	0.0017	0.00398	CbGbCtD
Zileuton—ALOX5—hematopoietic system—hematologic cancer	0.00162	0.0506	CbGeAlD
Zileuton—EPHX2—lung—hematologic cancer	0.00157	0.049	CbGeAlD
Zileuton—EPHX2—testis—hematologic cancer	0.00149	0.0462	CbGeAlD
Zileuton—LTB4R—lymph node—hematologic cancer	0.00146	0.0456	CbGeAlD
Zileuton—CYP3A4—Doxorubicin—hematologic cancer	0.00141	0.0033	CbGbCtD
Zileuton—EPHX2—lymph node—hematologic cancer	0.00108	0.0335	CbGeAlD
Zileuton—ALOX5—blood—hematologic cancer	0.00108	0.0335	CbGeAlD
Zileuton—ALOX5—bone marrow—hematologic cancer	0.00104	0.0324	CbGeAlD
Zileuton—ALOX5—lung—hematologic cancer	0.000943	0.0294	CbGeAlD
Zileuton—ALOX5—testis—hematologic cancer	0.00089	0.0277	CbGeAlD
Zileuton—CYP1A2—hematopoietic system—hematologic cancer	0.000752	0.0234	CbGeAlD
Zileuton—CYP2C9—hematopoietic system—hematologic cancer	0.000714	0.0222	CbGeAlD
Zileuton—PTGS1—hematopoietic system—hematologic cancer	0.000652	0.0203	CbGeAlD
Zileuton—ALOX5—lymph node—hematologic cancer	0.000645	0.0201	CbGeAlD
Zileuton—CYP3A4—hematopoietic system—hematologic cancer	0.000545	0.017	CbGeAlD
Zileuton—CYP1A2—blood—hematologic cancer	0.000498	0.0155	CbGeAlD
Zileuton—CYP2C9—blood—hematologic cancer	0.000473	0.0147	CbGeAlD
Zileuton—CYP1A2—lung—hematologic cancer	0.000437	0.0136	CbGeAlD
Zileuton—PTGS1—blood—hematologic cancer	0.000432	0.0134	CbGeAlD
Zileuton—PTGS1—lung—hematologic cancer	0.000379	0.0118	CbGeAlD
Zileuton—CYP3A4—blood—hematologic cancer	0.000361	0.0112	CbGeAlD
Zileuton—PTGS1—testis—hematologic cancer	0.000357	0.0111	CbGeAlD
Zileuton—PTGS1—lymph node—hematologic cancer	0.000259	0.00806	CbGeAlD
Zileuton—Dermatitis—Thiotepa—hematologic cancer	6e-05	0.000427	CcSEcCtD
Zileuton—Diarrhoea—Alitretinoin—hematologic cancer	6e-05	0.000427	CcSEcCtD
Zileuton—Headache—Thiotepa—hematologic cancer	5.97e-05	0.000424	CcSEcCtD
Zileuton—Diarrhoea—Ifosfamide—hematologic cancer	5.93e-05	0.000422	CcSEcCtD
Zileuton—Nausea—Vinorelbine—hematologic cancer	5.92e-05	0.000421	CcSEcCtD
Zileuton—Gastrointestinal disorder—Etoposide—hematologic cancer	5.91e-05	0.00042	CcSEcCtD
Zileuton—Body temperature increased—Cisplatin—hematologic cancer	5.9e-05	0.00042	CcSEcCtD
Zileuton—Myalgia—Betamethasone—hematologic cancer	5.87e-05	0.000418	CcSEcCtD
Zileuton—Myalgia—Dexamethasone—hematologic cancer	5.87e-05	0.000418	CcSEcCtD
Zileuton—Jaundice—Epirubicin—hematologic cancer	5.86e-05	0.000417	CcSEcCtD
Zileuton—Vomiting—Thalidomide—hematologic cancer	5.86e-05	0.000417	CcSEcCtD
Zileuton—Dizziness—Carmustine—hematologic cancer	5.85e-05	0.000416	CcSEcCtD
Zileuton—Pain—Etoposide—hematologic cancer	5.85e-05	0.000416	CcSEcCtD
Zileuton—Constipation—Etoposide—hematologic cancer	5.85e-05	0.000416	CcSEcCtD
Zileuton—Conjunctivitis—Epirubicin—hematologic cancer	5.84e-05	0.000416	CcSEcCtD
Zileuton—Urinary tract infection—Epirubicin—hematologic cancer	5.84e-05	0.000416	CcSEcCtD
Zileuton—Rash—Thalidomide—hematologic cancer	5.81e-05	0.000413	CcSEcCtD
Zileuton—Discomfort—Dexamethasone—hematologic cancer	5.8e-05	0.000413	CcSEcCtD
Zileuton—Discomfort—Betamethasone—hematologic cancer	5.8e-05	0.000413	CcSEcCtD
Zileuton—Dermatitis—Thalidomide—hematologic cancer	5.8e-05	0.000413	CcSEcCtD
Zileuton—Upper respiratory tract infection—Doxorubicin—hematologic cancer	5.8e-05	0.000412	CcSEcCtD
Zileuton—Dizziness—Alitretinoin—hematologic cancer	5.8e-05	0.000412	CcSEcCtD
Zileuton—Diarrhoea—Vincristine—hematologic cancer	5.78e-05	0.000411	CcSEcCtD
Zileuton—Headache—Thalidomide—hematologic cancer	5.77e-05	0.00041	CcSEcCtD
Zileuton—Pain—Prednisolone—hematologic cancer	5.77e-05	0.00041	CcSEcCtD
Zileuton—Hepatitis—Methotrexate—hematologic cancer	5.77e-05	0.00041	CcSEcCtD
Zileuton—Dizziness—Ifosfamide—hematologic cancer	5.73e-05	0.000407	CcSEcCtD
Zileuton—Pruritus—Gemcitabine—hematologic cancer	5.67e-05	0.000403	CcSEcCtD
Zileuton—Nausea—Thiotepa—hematologic cancer	5.66e-05	0.000402	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	5.65e-05	0.000402	CcSEcCtD
Zileuton—Sinusitis—Epirubicin—hematologic cancer	5.64e-05	0.000401	CcSEcCtD
Zileuton—Feeling abnormal—Etoposide—hematologic cancer	5.64e-05	0.000401	CcSEcCtD
Zileuton—Diarrhoea—Irinotecan—hematologic cancer	5.63e-05	0.0004	CcSEcCtD
Zileuton—Diarrhoea—Mitoxantrone—hematologic cancer	5.63e-05	0.0004	CcSEcCtD
Zileuton—Vomiting—Carmustine—hematologic cancer	5.63e-05	0.0004	CcSEcCtD
Zileuton—Insomnia—Triamcinolone—hematologic cancer	5.61e-05	0.000399	CcSEcCtD
Zileuton—Dizziness—Vincristine—hematologic cancer	5.59e-05	0.000397	CcSEcCtD
Zileuton—Rash—Carmustine—hematologic cancer	5.58e-05	0.000397	CcSEcCtD
Zileuton—Ill-defined disorder—Prednisone—hematologic cancer	5.57e-05	0.000396	CcSEcCtD
Zileuton—Dermatitis—Carmustine—hematologic cancer	5.57e-05	0.000396	CcSEcCtD
Zileuton—Vomiting—Alitretinoin—hematologic cancer	5.57e-05	0.000396	CcSEcCtD
Zileuton—Feeling abnormal—Prednisolone—hematologic cancer	5.56e-05	0.000395	CcSEcCtD
Zileuton—Headache—Carmustine—hematologic cancer	5.54e-05	0.000394	CcSEcCtD
Zileuton—Rash—Alitretinoin—hematologic cancer	5.53e-05	0.000393	CcSEcCtD
Zileuton—Dermatitis—Alitretinoin—hematologic cancer	5.52e-05	0.000393	CcSEcCtD
Zileuton—Vomiting—Ifosfamide—hematologic cancer	5.51e-05	0.000392	CcSEcCtD
Zileuton—Hypersensitivity—Cisplatin—hematologic cancer	5.5e-05	0.000391	CcSEcCtD
Zileuton—Headache—Alitretinoin—hematologic cancer	5.49e-05	0.000391	CcSEcCtD
Zileuton—Diarrhoea—Gemcitabine—hematologic cancer	5.48e-05	0.00039	CcSEcCtD
Zileuton—Nausea—Thalidomide—hematologic cancer	5.47e-05	0.000389	CcSEcCtD
Zileuton—Dyspepsia—Triamcinolone—hematologic cancer	5.46e-05	0.000389	CcSEcCtD
Zileuton—Rash—Ifosfamide—hematologic cancer	5.46e-05	0.000388	CcSEcCtD
Zileuton—Dermatitis—Ifosfamide—hematologic cancer	5.46e-05	0.000388	CcSEcCtD
Zileuton—Dizziness—Irinotecan—hematologic cancer	5.44e-05	0.000387	CcSEcCtD
Zileuton—Urticaria—Etoposide—hematologic cancer	5.44e-05	0.000387	CcSEcCtD
Zileuton—Jaundice—Doxorubicin—hematologic cancer	5.42e-05	0.000386	CcSEcCtD
Zileuton—Malaise—Prednisone—hematologic cancer	5.42e-05	0.000385	CcSEcCtD
Zileuton—Body temperature increased—Etoposide—hematologic cancer	5.41e-05	0.000385	CcSEcCtD
Zileuton—Conjunctivitis—Doxorubicin—hematologic cancer	5.41e-05	0.000385	CcSEcCtD
Zileuton—Urinary tract infection—Doxorubicin—hematologic cancer	5.41e-05	0.000385	CcSEcCtD
Zileuton—Hepatitis—Epirubicin—hematologic cancer	5.4e-05	0.000384	CcSEcCtD
Zileuton—Vomiting—Vincristine—hematologic cancer	5.37e-05	0.000382	CcSEcCtD
Zileuton—Urticaria—Prednisolone—hematologic cancer	5.36e-05	0.000381	CcSEcCtD
Zileuton—Rash—Vincristine—hematologic cancer	5.33e-05	0.000379	CcSEcCtD
Zileuton—Dermatitis—Vincristine—hematologic cancer	5.32e-05	0.000378	CcSEcCtD
Zileuton—Pain—Triamcinolone—hematologic cancer	5.31e-05	0.000377	CcSEcCtD
Zileuton—Headache—Vincristine—hematologic cancer	5.29e-05	0.000376	CcSEcCtD
Zileuton—Nausea—Carmustine—hematologic cancer	5.26e-05	0.000374	CcSEcCtD
Zileuton—Vomiting—Mitoxantrone—hematologic cancer	5.23e-05	0.000372	CcSEcCtD
Zileuton—Vomiting—Irinotecan—hematologic cancer	5.23e-05	0.000372	CcSEcCtD
Zileuton—Sinusitis—Doxorubicin—hematologic cancer	5.22e-05	0.000371	CcSEcCtD
Zileuton—Nausea—Alitretinoin—hematologic cancer	5.21e-05	0.00037	CcSEcCtD
Zileuton—Rash—Irinotecan—hematologic cancer	5.19e-05	0.000369	CcSEcCtD
Zileuton—Rash—Mitoxantrone—hematologic cancer	5.19e-05	0.000369	CcSEcCtD
Zileuton—Dermatitis—Mitoxantrone—hematologic cancer	5.18e-05	0.000369	CcSEcCtD
Zileuton—Dermatitis—Irinotecan—hematologic cancer	5.18e-05	0.000369	CcSEcCtD
Zileuton—Headache—Irinotecan—hematologic cancer	5.15e-05	0.000366	CcSEcCtD
Zileuton—Headache—Mitoxantrone—hematologic cancer	5.15e-05	0.000366	CcSEcCtD
Zileuton—Nausea—Ifosfamide—hematologic cancer	5.15e-05	0.000366	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Betamethasone—hematologic cancer	5.13e-05	0.000365	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	5.13e-05	0.000365	CcSEcCtD
Zileuton—Arthralgia—Prednisone—hematologic cancer	5.12e-05	0.000364	CcSEcCtD
Zileuton—Myalgia—Prednisone—hematologic cancer	5.12e-05	0.000364	CcSEcCtD
Zileuton—Feeling abnormal—Triamcinolone—hematologic cancer	5.11e-05	0.000364	CcSEcCtD
Zileuton—Diarrhoea—Cisplatin—hematologic cancer	5.11e-05	0.000363	CcSEcCtD
Zileuton—Vomiting—Gemcitabine—hematologic cancer	5.09e-05	0.000362	CcSEcCtD
Zileuton—Insomnia—Betamethasone—hematologic cancer	5.09e-05	0.000362	CcSEcCtD
Zileuton—Insomnia—Dexamethasone—hematologic cancer	5.09e-05	0.000362	CcSEcCtD
Zileuton—Discomfort—Prednisone—hematologic cancer	5.05e-05	0.000359	CcSEcCtD
Zileuton—Rash—Gemcitabine—hematologic cancer	5.05e-05	0.000359	CcSEcCtD
Zileuton—Dermatitis—Gemcitabine—hematologic cancer	5.05e-05	0.000359	CcSEcCtD
Zileuton—Hypersensitivity—Etoposide—hematologic cancer	5.04e-05	0.000359	CcSEcCtD
Zileuton—Headache—Gemcitabine—hematologic cancer	5.02e-05	0.000357	CcSEcCtD
Zileuton—Nausea—Vincristine—hematologic cancer	5.02e-05	0.000357	CcSEcCtD
Zileuton—Hepatitis—Doxorubicin—hematologic cancer	4.99e-05	0.000355	CcSEcCtD
Zileuton—Hypersensitivity—Prednisolone—hematologic cancer	4.97e-05	0.000354	CcSEcCtD
Zileuton—Dyspepsia—Dexamethasone—hematologic cancer	4.96e-05	0.000353	CcSEcCtD
Zileuton—Dyspepsia—Betamethasone—hematologic cancer	4.96e-05	0.000353	CcSEcCtD
Zileuton—Urticaria—Triamcinolone—hematologic cancer	4.93e-05	0.000351	CcSEcCtD
Zileuton—Body temperature increased—Triamcinolone—hematologic cancer	4.91e-05	0.000349	CcSEcCtD
Zileuton—Nausea—Irinotecan—hematologic cancer	4.89e-05	0.000347	CcSEcCtD
Zileuton—Nausea—Mitoxantrone—hematologic cancer	4.89e-05	0.000347	CcSEcCtD
Zileuton—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.86e-05	0.000346	CcSEcCtD
Zileuton—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.86e-05	0.000346	CcSEcCtD
Zileuton—Pruritus—Etoposide—hematologic cancer	4.84e-05	0.000344	CcSEcCtD
Zileuton—Pain—Dexamethasone—hematologic cancer	4.82e-05	0.000342	CcSEcCtD
Zileuton—Pain—Betamethasone—hematologic cancer	4.82e-05	0.000342	CcSEcCtD
Zileuton—Nausea—Gemcitabine—hematologic cancer	4.76e-05	0.000338	CcSEcCtD
Zileuton—Vomiting—Cisplatin—hematologic cancer	4.75e-05	0.000338	CcSEcCtD
Zileuton—Rash—Cisplatin—hematologic cancer	4.71e-05	0.000335	CcSEcCtD
Zileuton—Dermatitis—Cisplatin—hematologic cancer	4.7e-05	0.000335	CcSEcCtD
Zileuton—Diarrhoea—Etoposide—hematologic cancer	4.68e-05	0.000333	CcSEcCtD
Zileuton—Ill-defined disorder—Methotrexate—hematologic cancer	4.66e-05	0.000331	CcSEcCtD
Zileuton—Feeling abnormal—Betamethasone—hematologic cancer	4.64e-05	0.00033	CcSEcCtD
Zileuton—Feeling abnormal—Dexamethasone—hematologic cancer	4.64e-05	0.00033	CcSEcCtD
Zileuton—Flatulence—Epirubicin—hematologic cancer	4.63e-05	0.000329	CcSEcCtD
Zileuton—Tension—Epirubicin—hematologic cancer	4.61e-05	0.000328	CcSEcCtD
Zileuton—Hypersensitivity—Triamcinolone—hematologic cancer	4.57e-05	0.000325	CcSEcCtD
Zileuton—Nervousness—Epirubicin—hematologic cancer	4.56e-05	0.000325	CcSEcCtD
Zileuton—Malaise—Methotrexate—hematologic cancer	4.53e-05	0.000322	CcSEcCtD
Zileuton—Dizziness—Etoposide—hematologic cancer	4.52e-05	0.000322	CcSEcCtD
Zileuton—Urticaria—Dexamethasone—hematologic cancer	4.47e-05	0.000318	CcSEcCtD
Zileuton—Urticaria—Betamethasone—hematologic cancer	4.47e-05	0.000318	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.47e-05	0.000318	CcSEcCtD
Zileuton—Dizziness—Prednisolone—hematologic cancer	4.46e-05	0.000317	CcSEcCtD
Zileuton—Body temperature increased—Betamethasone—hematologic cancer	4.45e-05	0.000317	CcSEcCtD
Zileuton—Body temperature increased—Dexamethasone—hematologic cancer	4.45e-05	0.000317	CcSEcCtD
Zileuton—Nausea—Cisplatin—hematologic cancer	4.44e-05	0.000315	CcSEcCtD
Zileuton—Insomnia—Prednisone—hematologic cancer	4.44e-05	0.000315	CcSEcCtD
Zileuton—Pruritus—Triamcinolone—hematologic cancer	4.39e-05	0.000312	CcSEcCtD
Zileuton—Ill-defined disorder—Epirubicin—hematologic cancer	4.36e-05	0.00031	CcSEcCtD
Zileuton—Vomiting—Etoposide—hematologic cancer	4.35e-05	0.000309	CcSEcCtD
Zileuton—Dyspepsia—Prednisone—hematologic cancer	4.32e-05	0.000307	CcSEcCtD
Zileuton—Rash—Etoposide—hematologic cancer	4.31e-05	0.000307	CcSEcCtD
Zileuton—Dermatitis—Etoposide—hematologic cancer	4.31e-05	0.000307	CcSEcCtD
Zileuton—Headache—Etoposide—hematologic cancer	4.29e-05	0.000305	CcSEcCtD
Zileuton—Flatulence—Doxorubicin—hematologic cancer	4.28e-05	0.000305	CcSEcCtD
Zileuton—Arthralgia—Methotrexate—hematologic cancer	4.27e-05	0.000304	CcSEcCtD
Zileuton—Chest pain—Methotrexate—hematologic cancer	4.27e-05	0.000304	CcSEcCtD
Zileuton—Myalgia—Methotrexate—hematologic cancer	4.27e-05	0.000304	CcSEcCtD
Zileuton—Tension—Doxorubicin—hematologic cancer	4.27e-05	0.000303	CcSEcCtD
Zileuton—Rash—Prednisolone—hematologic cancer	4.25e-05	0.000303	CcSEcCtD
Zileuton—Dermatitis—Prednisolone—hematologic cancer	4.25e-05	0.000302	CcSEcCtD
Zileuton—Malaise—Epirubicin—hematologic cancer	4.24e-05	0.000301	CcSEcCtD
Zileuton—Headache—Prednisolone—hematologic cancer	4.23e-05	0.000301	CcSEcCtD
Zileuton—Discomfort—Methotrexate—hematologic cancer	4.22e-05	0.0003	CcSEcCtD
Zileuton—Nervousness—Doxorubicin—hematologic cancer	4.22e-05	0.0003	CcSEcCtD
Zileuton—Constipation—Prednisone—hematologic cancer	4.19e-05	0.000298	CcSEcCtD
Zileuton—Dizziness—Triamcinolone—hematologic cancer	4.1e-05	0.000292	CcSEcCtD
Zileuton—Nausea—Etoposide—hematologic cancer	4.06e-05	0.000289	CcSEcCtD
Zileuton—Feeling abnormal—Prednisone—hematologic cancer	4.04e-05	0.000287	CcSEcCtD
Zileuton—Ill-defined disorder—Doxorubicin—hematologic cancer	4.03e-05	0.000287	CcSEcCtD
Zileuton—Nausea—Prednisolone—hematologic cancer	4.01e-05	0.000285	CcSEcCtD
Zileuton—Chest pain—Epirubicin—hematologic cancer	4e-05	0.000285	CcSEcCtD
Zileuton—Myalgia—Epirubicin—hematologic cancer	4e-05	0.000285	CcSEcCtD
Zileuton—Arthralgia—Epirubicin—hematologic cancer	4e-05	0.000285	CcSEcCtD
Zileuton—Pruritus—Betamethasone—hematologic cancer	3.98e-05	0.000283	CcSEcCtD
Zileuton—Pruritus—Dexamethasone—hematologic cancer	3.98e-05	0.000283	CcSEcCtD
Zileuton—Discomfort—Epirubicin—hematologic cancer	3.95e-05	0.000281	CcSEcCtD
Zileuton—Vomiting—Triamcinolone—hematologic cancer	3.95e-05	0.000281	CcSEcCtD
Zileuton—Malaise—Doxorubicin—hematologic cancer	3.92e-05	0.000279	CcSEcCtD
Zileuton—Rash—Triamcinolone—hematologic cancer	3.91e-05	0.000278	CcSEcCtD
Zileuton—Dermatitis—Triamcinolone—hematologic cancer	3.91e-05	0.000278	CcSEcCtD
Zileuton—Urticaria—Prednisone—hematologic cancer	3.9e-05	0.000277	CcSEcCtD
Zileuton—Headache—Triamcinolone—hematologic cancer	3.89e-05	0.000276	CcSEcCtD
Zileuton—Body temperature increased—Prednisone—hematologic cancer	3.88e-05	0.000276	CcSEcCtD
Zileuton—Diarrhoea—Dexamethasone—hematologic cancer	3.85e-05	0.000274	CcSEcCtD
Zileuton—Diarrhoea—Betamethasone—hematologic cancer	3.85e-05	0.000274	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.73e-05	0.000266	CcSEcCtD
Zileuton—Dizziness—Dexamethasone—hematologic cancer	3.72e-05	0.000265	CcSEcCtD
Zileuton—Dizziness—Betamethasone—hematologic cancer	3.72e-05	0.000265	CcSEcCtD
Zileuton—Insomnia—Methotrexate—hematologic cancer	3.71e-05	0.000264	CcSEcCtD
Zileuton—Myalgia—Doxorubicin—hematologic cancer	3.7e-05	0.000263	CcSEcCtD
Zileuton—Chest pain—Doxorubicin—hematologic cancer	3.7e-05	0.000263	CcSEcCtD
Zileuton—Arthralgia—Doxorubicin—hematologic cancer	3.7e-05	0.000263	CcSEcCtD
Zileuton—Nausea—Triamcinolone—hematologic cancer	3.69e-05	0.000262	CcSEcCtD
Zileuton—Discomfort—Doxorubicin—hematologic cancer	3.66e-05	0.00026	CcSEcCtD
Zileuton—Somnolence—Methotrexate—hematologic cancer	3.64e-05	0.000259	CcSEcCtD
Zileuton—Hypersensitivity—Prednisone—hematologic cancer	3.61e-05	0.000257	CcSEcCtD
Zileuton—Dyspepsia—Methotrexate—hematologic cancer	3.61e-05	0.000257	CcSEcCtD
Zileuton—Vomiting—Dexamethasone—hematologic cancer	3.58e-05	0.000255	CcSEcCtD
Zileuton—Vomiting—Betamethasone—hematologic cancer	3.58e-05	0.000255	CcSEcCtD
Zileuton—Rash—Dexamethasone—hematologic cancer	3.55e-05	0.000253	CcSEcCtD
Zileuton—Rash—Betamethasone—hematologic cancer	3.55e-05	0.000253	CcSEcCtD
Zileuton—Dermatitis—Betamethasone—hematologic cancer	3.55e-05	0.000252	CcSEcCtD
Zileuton—Dermatitis—Dexamethasone—hematologic cancer	3.55e-05	0.000252	CcSEcCtD
Zileuton—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.54e-05	0.000252	CcSEcCtD
Zileuton—Headache—Dexamethasone—hematologic cancer	3.53e-05	0.000251	CcSEcCtD
Zileuton—Headache—Betamethasone—hematologic cancer	3.53e-05	0.000251	CcSEcCtD
Zileuton—Pain—Methotrexate—hematologic cancer	3.5e-05	0.000249	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.49e-05	0.000249	CcSEcCtD
Zileuton—Pruritus—Prednisone—hematologic cancer	3.47e-05	0.000247	CcSEcCtD
Zileuton—Insomnia—Epirubicin—hematologic cancer	3.47e-05	0.000247	CcSEcCtD
Zileuton—Somnolence—Epirubicin—hematologic cancer	3.41e-05	0.000242	CcSEcCtD
Zileuton—Feeling abnormal—Methotrexate—hematologic cancer	3.38e-05	0.00024	CcSEcCtD
Zileuton—Dyspepsia—Epirubicin—hematologic cancer	3.38e-05	0.00024	CcSEcCtD
Zileuton—Diarrhoea—Prednisone—hematologic cancer	3.36e-05	0.000239	CcSEcCtD
Zileuton—Nausea—Dexamethasone—hematologic cancer	3.34e-05	0.000238	CcSEcCtD
Zileuton—Nausea—Betamethasone—hematologic cancer	3.34e-05	0.000238	CcSEcCtD
Zileuton—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.31e-05	0.000235	CcSEcCtD
Zileuton—Pain—Epirubicin—hematologic cancer	3.28e-05	0.000233	CcSEcCtD
Zileuton—Constipation—Epirubicin—hematologic cancer	3.28e-05	0.000233	CcSEcCtD
Zileuton—Urticaria—Methotrexate—hematologic cancer	3.26e-05	0.000232	CcSEcCtD
Zileuton—Dizziness—Prednisone—hematologic cancer	3.24e-05	0.000231	CcSEcCtD
Zileuton—Body temperature increased—Methotrexate—hematologic cancer	3.24e-05	0.00023	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.23e-05	0.00023	CcSEcCtD
Zileuton—Insomnia—Doxorubicin—hematologic cancer	3.21e-05	0.000228	CcSEcCtD
Zileuton—Feeling abnormal—Epirubicin—hematologic cancer	3.16e-05	0.000225	CcSEcCtD
Zileuton—Somnolence—Doxorubicin—hematologic cancer	3.15e-05	0.000224	CcSEcCtD
Zileuton—Dyspepsia—Doxorubicin—hematologic cancer	3.12e-05	0.000222	CcSEcCtD
Zileuton—Vomiting—Prednisone—hematologic cancer	3.12e-05	0.000222	CcSEcCtD
Zileuton—Rash—Prednisone—hematologic cancer	3.09e-05	0.00022	CcSEcCtD
Zileuton—Dermatitis—Prednisone—hematologic cancer	3.09e-05	0.00022	CcSEcCtD
Zileuton—Headache—Prednisone—hematologic cancer	3.07e-05	0.000218	CcSEcCtD
Zileuton—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.06e-05	0.000218	CcSEcCtD
Zileuton—Urticaria—Epirubicin—hematologic cancer	3.05e-05	0.000217	CcSEcCtD
Zileuton—Constipation—Doxorubicin—hematologic cancer	3.03e-05	0.000216	CcSEcCtD
Zileuton—Pain—Doxorubicin—hematologic cancer	3.03e-05	0.000216	CcSEcCtD
Zileuton—Body temperature increased—Epirubicin—hematologic cancer	3.03e-05	0.000216	CcSEcCtD
Zileuton—Hypersensitivity—Methotrexate—hematologic cancer	3.02e-05	0.000215	CcSEcCtD
Zileuton—Feeling abnormal—Doxorubicin—hematologic cancer	2.92e-05	0.000208	CcSEcCtD
Zileuton—Nausea—Prednisone—hematologic cancer	2.91e-05	0.000207	CcSEcCtD
Zileuton—Pruritus—Methotrexate—hematologic cancer	2.9e-05	0.000206	CcSEcCtD
Zileuton—Hypersensitivity—Epirubicin—hematologic cancer	2.83e-05	0.000201	CcSEcCtD
Zileuton—Urticaria—Doxorubicin—hematologic cancer	2.82e-05	0.0002	CcSEcCtD
Zileuton—Body temperature increased—Doxorubicin—hematologic cancer	2.81e-05	0.0002	CcSEcCtD
Zileuton—Diarrhoea—Methotrexate—hematologic cancer	2.8e-05	0.000199	CcSEcCtD
Zileuton—Pruritus—Epirubicin—hematologic cancer	2.71e-05	0.000193	CcSEcCtD
Zileuton—Dizziness—Methotrexate—hematologic cancer	2.71e-05	0.000193	CcSEcCtD
Zileuton—Diarrhoea—Epirubicin—hematologic cancer	2.62e-05	0.000187	CcSEcCtD
Zileuton—Hypersensitivity—Doxorubicin—hematologic cancer	2.61e-05	0.000186	CcSEcCtD
Zileuton—Vomiting—Methotrexate—hematologic cancer	2.61e-05	0.000185	CcSEcCtD
Zileuton—Rash—Methotrexate—hematologic cancer	2.58e-05	0.000184	CcSEcCtD
Zileuton—Dermatitis—Methotrexate—hematologic cancer	2.58e-05	0.000184	CcSEcCtD
Zileuton—Headache—Methotrexate—hematologic cancer	2.57e-05	0.000183	CcSEcCtD
Zileuton—Dizziness—Epirubicin—hematologic cancer	2.54e-05	0.00018	CcSEcCtD
Zileuton—Pruritus—Doxorubicin—hematologic cancer	2.51e-05	0.000179	CcSEcCtD
Zileuton—Vomiting—Epirubicin—hematologic cancer	2.44e-05	0.000173	CcSEcCtD
Zileuton—Nausea—Methotrexate—hematologic cancer	2.43e-05	0.000173	CcSEcCtD
Zileuton—Diarrhoea—Doxorubicin—hematologic cancer	2.43e-05	0.000173	CcSEcCtD
Zileuton—Rash—Epirubicin—hematologic cancer	2.42e-05	0.000172	CcSEcCtD
Zileuton—Dermatitis—Epirubicin—hematologic cancer	2.42e-05	0.000172	CcSEcCtD
Zileuton—Headache—Epirubicin—hematologic cancer	2.4e-05	0.000171	CcSEcCtD
Zileuton—Dizziness—Doxorubicin—hematologic cancer	2.35e-05	0.000167	CcSEcCtD
Zileuton—Nausea—Epirubicin—hematologic cancer	2.28e-05	0.000162	CcSEcCtD
Zileuton—Vomiting—Doxorubicin—hematologic cancer	2.26e-05	0.00016	CcSEcCtD
Zileuton—Rash—Doxorubicin—hematologic cancer	2.24e-05	0.000159	CcSEcCtD
Zileuton—Dermatitis—Doxorubicin—hematologic cancer	2.24e-05	0.000159	CcSEcCtD
Zileuton—Headache—Doxorubicin—hematologic cancer	2.22e-05	0.000158	CcSEcCtD
Zileuton—Nausea—Doxorubicin—hematologic cancer	2.11e-05	0.00015	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—EP300—hematologic cancer	8.86e-06	0.000142	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ENO2—hematologic cancer	8.82e-06	0.000142	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—NQO1—hematologic cancer	8.72e-06	0.00014	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CD44—hematologic cancer	8.72e-06	0.00014	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CREBBP—hematologic cancer	8.65e-06	0.000139	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SRC—hematologic cancer	8.61e-06	0.000138	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTT1—hematologic cancer	8.55e-06	0.000137	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.54e-06	0.000137	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	8.43e-06	0.000135	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SMPD3—hematologic cancer	8.42e-06	0.000135	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.42e-06	0.000135	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—VEGFA—hematologic cancer	8.39e-06	0.000135	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—SDC1—hematologic cancer	8.36e-06	0.000134	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—STAT3—hematologic cancer	8.31e-06	0.000133	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NRAS—hematologic cancer	8.29e-06	0.000133	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CDA—hematologic cancer	8.27e-06	0.000133	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CYCS—hematologic cancer	8.25e-06	0.000133	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—MTAP—hematologic cancer	8.23e-06	0.000132	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CD—hematologic cancer	8.2e-06	0.000132	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—HSP90AA1—hematologic cancer	8.2e-06	0.000132	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ALB—hematologic cancer	8.1e-06	0.00013	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.99e-06	0.000128	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PC—hematologic cancer	7.96e-06	0.000128	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MAPK3—hematologic cancer	7.94e-06	0.000127	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.88e-06	0.000127	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CA—hematologic cancer	7.84e-06	0.000126	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3R1—hematologic cancer	7.75e-06	0.000124	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MYC—hematologic cancer	7.72e-06	0.000124	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TGFB1—hematologic cancer	7.7e-06	0.000124	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GBA—hematologic cancer	7.69e-06	0.000124	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SLC35B2—hematologic cancer	7.69e-06	0.000124	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.54e-06	0.000121	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.38e-06	0.000119	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ASNS—hematologic cancer	7.36e-06	0.000118	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—DCK—hematologic cancer	7.36e-06	0.000118	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—B3GAT1—hematologic cancer	7.36e-06	0.000118	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—FHL2—hematologic cancer	7.34e-06	0.000118	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSTP1—hematologic cancer	7.27e-06	0.000117	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AGRN—hematologic cancer	7.2e-06	0.000116	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CB—hematologic cancer	7.15e-06	0.000115	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—KRAS—hematologic cancer	7.13e-06	0.000115	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CD44—hematologic cancer	7.11e-06	0.000114	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—NQO1—hematologic cancer	7.11e-06	0.000114	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.04e-06	0.000113	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—MTAP—hematologic cancer	7.03e-06	0.000113	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—HDC—hematologic cancer	6.98e-06	0.000112	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.96e-06	0.000112	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ABCB1—hematologic cancer	6.89e-06	0.000111	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—IDH2—hematologic cancer	6.82e-06	0.00011	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—HMMR—hematologic cancer	6.82e-06	0.00011	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYCS—hematologic cancer	6.73e-06	0.000108	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—HSP90AA1—hematologic cancer	6.68e-06	0.000107	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSTM1—hematologic cancer	6.68e-06	0.000107	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—NCOR1—hematologic cancer	6.68e-06	0.000107	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CA—hematologic cancer	6.55e-06	0.000105	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.43e-06	0.000103	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ARNTL—hematologic cancer	6.41e-06	0.000103	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—AKT1—hematologic cancer	6.4e-06	0.000103	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CDA—hematologic cancer	6.38e-06	0.000103	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TP53—hematologic cancer	6.34e-06	0.000102	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—FHL2—hematologic cancer	6.27e-06	0.000101	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CA9—hematologic cancer	6.24e-06	0.0001	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ACP5—hematologic cancer	6.24e-06	0.0001	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTEN—hematologic cancer	6.18e-06	9.92e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NCOR2—hematologic cancer	6.16e-06	9.89e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AGRN—hematologic cancer	6.15e-06	9.88e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PC—hematologic cancer	6.15e-06	9.87e-05	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—HRAS—hematologic cancer	6.06e-06	9.74e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.02e-06	9.66e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GBA—hematologic cancer	5.94e-06	9.53e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.94e-06	9.53e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTP1—hematologic cancer	5.93e-06	9.52e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—MTHFR—hematologic cancer	5.91e-06	9.49e-05	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—EP300—hematologic cancer	5.89e-06	9.46e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—IDH1—hematologic cancer	5.87e-06	9.42e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—HMMR—hematologic cancer	5.83e-06	9.36e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—IDH2—hematologic cancer	5.83e-06	9.36e-05	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL6—hematologic cancer	5.8e-06	9.32e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ABCC3—hematologic cancer	5.8e-06	9.32e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—TXN—hematologic cancer	5.8e-06	9.32e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTO1—hematologic cancer	5.8e-06	9.32e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.74e-06	9.21e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SPHK1—hematologic cancer	5.68e-06	9.12e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ABCB1—hematologic cancer	5.61e-06	9.02e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.5e-06	8.83e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ARNTL—hematologic cancer	5.48e-06	8.8e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—UGT1A1—hematologic cancer	5.45e-06	8.76e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTM1—hematologic cancer	5.45e-06	8.75e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—NCOR1—hematologic cancer	5.45e-06	8.75e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—MTAP—hematologic cancer	5.43e-06	8.72e-05	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AKT1—hematologic cancer	5.35e-06	8.6e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CA9—hematologic cancer	5.33e-06	8.56e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ACP5—hematologic cancer	5.33e-06	8.56e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SLC22A1—hematologic cancer	5.3e-06	8.52e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CRABP1—hematologic cancer	5.3e-06	8.52e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NCOR2—hematologic cancer	5.26e-06	8.45e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.21e-06	8.36e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALOX5—hematologic cancer	5.17e-06	8.3e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—IDH1—hematologic cancer	5.01e-06	8.05e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NUP98—hematologic cancer	5.01e-06	8.04e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CG—hematologic cancer	4.96e-06	7.97e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTO1—hematologic cancer	4.96e-06	7.96e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCC3—hematologic cancer	4.96e-06	7.96e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—TXN—hematologic cancer	4.96e-06	7.96e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ADCY7—hematologic cancer	4.86e-06	7.81e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NCOA3—hematologic cancer	4.86e-06	7.81e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.85e-06	7.79e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—FHL2—hematologic cancer	4.84e-06	7.77e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NUP214—hematologic cancer	4.83e-06	7.75e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—MTHFR—hematologic cancer	4.82e-06	7.74e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.78e-06	7.67e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AGRN—hematologic cancer	4.75e-06	7.62e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—MTR—hematologic cancer	4.73e-06	7.59e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ABCG2—hematologic cancer	4.73e-06	7.59e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.66e-06	7.48e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ENO2—hematologic cancer	4.64e-06	7.45e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CREBBP—hematologic cancer	4.6e-06	7.39e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CRABP1—hematologic cancer	4.53e-06	7.28e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SLC22A1—hematologic cancer	4.53e-06	7.28e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—IDH2—hematologic cancer	4.5e-06	7.23e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—HMMR—hematologic cancer	4.5e-06	7.23e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTT1—hematologic cancer	4.5e-06	7.22e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.43e-06	7.11e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALOX5—hematologic cancer	4.42e-06	7.1e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SDC1—hematologic cancer	4.4e-06	7.06e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CD—hematologic cancer	4.36e-06	7.01e-05	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CA—hematologic cancer	4.36e-06	7e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ALB—hematologic cancer	4.31e-06	6.92e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NUP98—hematologic cancer	4.28e-06	6.87e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.24e-06	6.82e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.23e-06	6.79e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.2e-06	6.74e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.15e-06	6.67e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.15e-06	6.67e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.14e-06	6.66e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NUP214—hematologic cancer	4.12e-06	6.62e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3R1—hematologic cancer	4.12e-06	6.62e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CA9—hematologic cancer	4.11e-06	6.61e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ACP5—hematologic cancer	4.11e-06	6.61e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.08e-06	6.56e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.06e-06	6.52e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CG—hematologic cancer	4.05e-06	6.5e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.04e-06	6.49e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—MTR—hematologic cancer	4.04e-06	6.49e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.96e-06	6.37e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ENO2—hematologic cancer	3.96e-06	6.36e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—IDH1—hematologic cancer	3.87e-06	6.21e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.84e-06	6.17e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.82e-06	6.14e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—TXN—hematologic cancer	3.82e-06	6.14e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.82e-06	6.14e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CB—hematologic cancer	3.8e-06	6.11e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.78e-06	6.08e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SDC1—hematologic cancer	3.76e-06	6.03e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CREBBP—hematologic cancer	3.75e-06	6.03e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.74e-06	6.01e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CD44—hematologic cancer	3.74e-06	6e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NQO1—hematologic cancer	3.74e-06	6e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.66e-06	5.88e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.6e-06	5.78e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.59e-06	5.76e-05	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—AKT1—hematologic cancer	3.56e-06	5.72e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CD—hematologic cancer	3.56e-06	5.71e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.54e-06	5.69e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYCS—hematologic cancer	3.54e-06	5.68e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.51e-06	5.64e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ALB—hematologic cancer	3.51e-06	5.64e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.5e-06	5.62e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.5e-06	5.62e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.41e-06	5.48e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.39e-06	5.44e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3R1—hematologic cancer	3.36e-06	5.39e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NUP98—hematologic cancer	3.3e-06	5.3e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTEN—hematologic cancer	3.29e-06	5.28e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.21e-06	5.15e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.21e-06	5.15e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NQO1—hematologic cancer	3.19e-06	5.13e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CD44—hematologic cancer	3.19e-06	5.13e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NUP214—hematologic cancer	3.18e-06	5.11e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.16e-06	5.08e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—EP300—hematologic cancer	3.13e-06	5.03e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.13e-06	5.02e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.12e-06	5.01e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—MTR—hematologic cancer	3.12e-06	5.01e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.12e-06	5.01e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CB—hematologic cancer	3.1e-06	4.98e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ENO2—hematologic cancer	3.06e-06	4.91e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYCS—hematologic cancer	3.02e-06	4.85e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.02e-06	4.84e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3e-06	4.82e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.97e-06	4.76e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.95e-06	4.74e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SDC1—hematologic cancer	2.9e-06	4.66e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.86e-06	4.6e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.86e-06	4.6e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.7e-06	4.34e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTEN—hematologic cancer	2.68e-06	4.3e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.66e-06	4.28e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.58e-06	4.14e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—EP300—hematologic cancer	2.55e-06	4.1e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.53e-06	4.07e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.52e-06	4.05e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CD44—hematologic cancer	2.46e-06	3.96e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NQO1—hematologic cancer	2.46e-06	3.96e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.45e-06	3.93e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.45e-06	3.93e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYCS—hematologic cancer	2.33e-06	3.75e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CA—hematologic cancer	2.32e-06	3.72e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.32e-06	3.72e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.23e-06	3.58e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.16e-06	3.47e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.13e-06	3.42e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.06e-06	3.3e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.97e-06	3.17e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.95e-06	3.13e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.91e-06	3.06e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—AKT1—hematologic cancer	1.89e-06	3.04e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CA—hematologic cancer	1.89e-06	3.04e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.89e-06	3.03e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.89e-06	3.03e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.87e-06	3e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALB—hematologic cancer	1.85e-06	2.96e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.82e-06	2.92e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.77e-06	2.84e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.69e-06	2.71e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.67e-06	2.68e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.63e-06	2.62e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.6e-06	2.57e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALB—hematologic cancer	1.58e-06	2.53e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—AKT1—hematologic cancer	1.54e-06	2.48e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.51e-06	2.42e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTEN—hematologic cancer	1.41e-06	2.26e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.4e-06	2.25e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.39e-06	2.24e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—EP300—hematologic cancer	1.34e-06	2.16e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.3e-06	2.09e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.23e-06	1.98e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALB—hematologic cancer	1.22e-06	1.96e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTEN—hematologic cancer	1.2e-06	1.93e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.16e-06	1.87e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—EP300—hematologic cancer	1.15e-06	1.84e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.07e-06	1.73e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CA—hematologic cancer	9.94e-07	1.6e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTEN—hematologic cancer	9.29e-07	1.49e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—EP300—hematologic cancer	8.86e-07	1.42e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CA—hematologic cancer	8.49e-07	1.36e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AKT1—hematologic cancer	8.12e-07	1.3e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AKT1—hematologic cancer	6.94e-07	1.11e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.55e-07	1.05e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AKT1—hematologic cancer	5.35e-07	8.6e-06	CbGpPWpGaD
